ArticleRenal failure2026
Association of environmental xylene exposure with diabetic kidney disease: a cross-sectional analysis and multi-omics evaluation of immune microenvironment mechanisms.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic kidney disease (DKD) progression is driven by residual inflammation, potentially exacerbated by volatile organic compounds (VOCs). However, the impact of xylene exposure on the DKD immune microenvironment remains unclear. We evaluated the association between urinary VOC metabolites and DKD prevalence using NHANES data. Network toxicology and bulk transcriptomics (GSE142025) were integrated to identify core targets and profile immune infiltration. Single-cell RNA sequencing (GSE209781) validated macrophage heterogeneity and hub gene dynamics, and molecular docking assessed xylene-receptor binding affinities. Elevated urinary xylene metabolite (DPMA) correlated with increased DKD odds (OR = 4.03, 95% CI: 1.80-9.00). Multi-omics identified ITGAM, CSF1R, and CTSS as primary hub genes enriched in immune pathways. Both bulk and single-cell RNA sequencing analyses revealed that DKD tissues exhibited M2-like macrophage enrichment and an expansion of fibrotic SPP1+ subsets. This altered microenvironment positively correlated with hub gene upregulation along the macrophage developmental trajectory. Molecular docking suggested potential binding between xylene isomers and these receptors (binding free energies: -4.7 to -5.9 kcal/mol). Environmental xylene exposure is independently associated with higher DKD odds. These findings generate the hypothesis that xylene may interact with specific macrophage receptors (ITGAM, CSF1R, CTSS), potentially promoting M2-like macrophage polarization and fibrotic remodeling. This putative environmental-immunological axis warrants further experimental validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.